Description: IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, para amino phenol, and mono chloro acetic acid to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.
Home Page: www.iolcp.com
85, Industrial Area 'A'
Ludhiana,
141003
India
Phone:
91 16 1222 5531
Officers
| Name | Title |
|---|---|
| Mr. Pardeep Kumar Khanna | Chief Financial Officer |
| Mr. Abhay Raj Singh | VP, Company Secretary & Compliance Officer |
| Mr. Varinder Gupta | MD & Whole Time Director |
| Mr. Vikas Gupta | Joint Managing Director & Executive Director |
| Mr. Kushal Kumar Rana | Director of Works & Wholetime Director |
| Mr. Abhiraj Gupta | Executive Director |
| Dr. Gurupur Ganesh Pai | Chief Technology Officer |
| Mr. Damandeep Singh | President of Project |
| Mr. Kamlesh Jayantilal Ranbhan | President of R&D |
| Mr. Gopal Singla | President of Engineering |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 22.887 |
| Price-to-Book MRQ: | 1.3758 |
| Price-to-Sales TTM: | 1.1104 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 2777 |